Terminated PHASE3 INTERVENTIONAL 2-arm NCT00912054

DuoTrav APS Versus XALACOM® in Ocular Surface Health

Sponsor: Alcon Research

Conditions Ocular Hypertension Open Angle Glaucoma

Updated 6 times since 2017 Last updated: Jul 17, 2012 Started: Mar 31, 2010 Primary completion: May 31, 2011 Completion: May 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

poor enrollment

Other terminated trials from Alcon Research

See all terminations from Alcon Research

Other Ocular Hypertension trials with similar outcome

Browse all Ocular Hypertension trials

This PHASE3 trial investigates Ocular Hypertension and Open Angle Glaucoma and is currently terminated or withdrawn. Alcon Research leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alcon Research

Data source: Alcon Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium